» Articles » PMID: 38806039

Blood Urea Nitrogen-to-Serum Albumin Ratio Predicts Fatal Outcomes in Severe Fever with Thrombocytopenia Syndrome Patients

Overview
Specialty Tropical Medicine
Date 2024 May 28
PMID 38806039
Authors
Affiliations
Soon will be listed here.
Abstract

There are no effective therapies for severe fever with thrombocytopenia syndrome (SFTS), and existing predictors of mortality are still controversial. This retrospective study aimed to identify reliable early-stage indicators for predicting fatal outcomes in 217 patients hospitalized with an SFTS diagnosis between March 2021 and November 2023; 157 of the patients survived, and 60 died. Demographics, clinical characteristics, and laboratory parameters were reassessed in both groups. The mean age of participants was 64.0 (interquartile range: 54.5-71.0) years, and 42.4% (92/217) were males. Based on a multivariate Cox regression analysis, the blood urea nitrogen-to-serum albumin ratio (BAR) (hazard ratio [HR]:4.751; 95% CI: 2.208-10.226; P <0.001), procalcitonin level (HR: 1.946; 95% CI: 1.080-3.507; P = 0.027), and central nervous system symptoms (HR: 3.257; 95% CI, 1.628-6.513; P = 0.001) were independent risk factors for mortality in SFTS patients. According to a receiver operating characteristic curve analysis, a BAR with an area under the curve of 0.913 (95% CI: 0.873-0.953; P <0.001), a sensitivity of 76.7%, and a specificity of 90.4% showed better predictive performance for fatal outcomes than other classical indicators reported. The Kaplan-Meier survival curve confirmed that an increased BAR was linked with an unfavorable prognosis in SFTS patients (P <0.001 by log-rank test). In conclusion, the results indicate that high BAR levels are markedly related to substandard outcomes and are a reliable and readily accessible predictor of fatal outcomes in SFTS patients.

Citing Articles

Prognostic nutritional index as an early predictor of mortality in patients with severe fever with thrombocytopenia syndrome: multicenter retrospective study in South Korea.

Woo H, Kwon T, Heo S, Yoo J, Kim M, Oh J BMC Infect Dis. 2025; 25(1):274.

PMID: 40001073 PMC: 11863440. DOI: 10.1186/s12879-025-10661-8.

References
1.
Gui Y, Xu Y, Yang P . Predictive Value of the Platelet-to-Albumin Ratio (PAR) on the Risk of Death at Admission in Patients Suffering from Severe Fever with Thrombocytopenia Syndrome. J Inflamm Res. 2021; 14:5647-5652. PMC: 8565980. DOI: 10.2147/JIR.S335727. View

2.
Li H, Lu Q, Xing B, Zhang S, Liu K, Du J . Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study. Lancet Infect Dis. 2018; 18(10):1127-1137. DOI: 10.1016/S1473-3099(18)30293-7. View

3.
Ulloque-Badaracco J, Alarcon-Braga E, Hernandez-Bustamante E, Al-Kassab-Cordova A, Mosquera-Rojas M, Ulloque-Badaracco R . Fibrinogen-to-Albumin Ratio and Blood Urea Nitrogen-to-Albumin Ratio in COVID-19 Patients: A Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2022; 7(8). PMC: 9414552. DOI: 10.3390/tropicalmed7080150. View

4.
Li X, Dai K, Yang Z, Yuan C, Cui N, Zhang S . Correlation between thrombocytopenia and host response in severe fever with thrombocytopenia syndrome. PLoS Negl Trop Dis. 2020; 14(10):e0008801. PMC: 7595704. DOI: 10.1371/journal.pntd.0008801. View

5.
Chen C, Li P, Li K, Wang H, Dai Y, Cheng X . Animals as amplification hosts in the spread of severe fever with thrombocytopenia syndrome virus: A systematic review and meta-analysis. Int J Infect Dis. 2018; 79:77-84. DOI: 10.1016/j.ijid.2018.11.017. View